Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 149-156

  Koehne, G ^a,b   Zeller, W ^a   Stockschlaeder, M ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CD4+ CD45RO+; Lymphocyte reconstitution; PBSCT; T cell isoforms

Indexed keywords

ALLOANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THYMUS; UMBILICAL CORD BLOOD;

EID: 0031035896     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700624     Document Type: Article

References (34)

1. Thomas ED. Marrow transplantation for malignant diseases. J Clin Oncol 1983; 1: 517-531.
2. Zander AR, Reuben JM, Johnston D et al. Immune recovery following allogeneic bone marrow transplantation. Transplantation 1985; 40: 177-183.
3. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
4. Meyers J. Infection in bone marrow transplant recipients. Am J Med 1986; 81: 27-31.
5. Henon PR, Liang H, Beckwirth G et al. Comparison of haemopoietic and immune recovery after autologous bone marrow transplantation or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
6. Zintl F, Prager J, Sauerbrey et al. Immunereconstitution after human bone marrow transplantation. Folia Haematol 1989; 116: 519-526.
7. Witherspoon RP, Storb R, Ochs H. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time post-transplantation, the presence or absence of chronic GVHD. and antithymocyte globulin treatment. Blood 1981; 58: 360-368.
8. Noel DR, Witherspoon RP, Storb R et al. Does GVHD influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 1978; 51: 1087-1105.
9. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
10. Ashihara E, Shimazaki C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two colour flow cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
11. Small TN, Keever CA, Weiner Fedus S et al. B-cell differentiation following autologous bone marrow transplantation, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76: 1647-1656.
12. Storek J, Ferrara S, Ku N et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387-398.
13. Clement LT, Grossi CE, Gartland L. Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B-cell differentiation. J Immunol 1984; 133: 2461-2468.
14. Velardi A, Terenzi A, Cucciaioni S et al. Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell population in the reconstitution phase after human marrow transplantation. Blood 1988; 71: 1196-1200.
15. Korsemeyer SJ, Elfenbein GJ, Goldman CK et al. B cell, helper T-cell, and suppressor T-cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation. Transplantation 1982; 33: 184-190.
16. Matsue K, Luni LG, Witherspoon RP, Storb R. Proliferative and differentiative responses of B cells from human marrow graft recipients to T-cell derived factors. Blood 1987; 69: 208-315.
17. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
18. Mitchie CA, McLean A, Alcock C, Beverley PC. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992; 360: 264.
19. Serra HM, Krowka JF, Ledbetter JA, Pilarski LM. Loss of CD45R (p220) represents a post-thymic T-cell differentiation event. J Immunol 1988; 140: 1435-1441.
20. Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoeisis and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143-149.
21. Mueller-Hermelink HK, Sale GE, Borisch B, Storb R. Pathology of the thymus after allogeneic bone marrow transplantation in man. Am J Pathol 1979; 129: 242-256.
22. Stutman O. Post-thymic T-cell development. Immunol Rev 1986; 91: 159-194.
23. Mackall CL, Graner L, Sheard M et al. T cell regeneration after bone marrow transplantation: differential CD45 isoforms expression on thymic-derived vs thymic-independent progeny. Blood 1993; 82: 2585-2594.
24. MacDonald HR, Blanc C, Lees RK, Sordat B. Abnormal distinction of T cell subsets in athymic mice. J Immunol 1986 136: 4337-4342.
25. Fritsch G, Schrimpl M, Kurz M et al. The composition of CD 34 subpopulations differ between bone marrow, blood and cord blood. Bone Marrow Transplant 1996; 17: 169-178.
26. Antin JH, Ault KA, Rapeport JM, Smith BR. B-lymphocyte reconstitution after human bone marrow transplantation. J Clin Invest 1987; 80: 325-332.
27. Linch DC, Knott LJ, Thomas RM et al. T-cell regeneration after alloseneic and autologous bone marrow transplantation. Br J Haematol 1983; 53: 451-158.
28. Armitage R,. Goldstone AH, Richards JD, Cawley JC. Lymphocyte function after autologous bone marrow transplantation (BMT): a comparison with patients treated with allogeneic BMT and with chemotherapy. Br J Haematol 1986; 63: 637-647.
29. Neubauer MA, Benyumes MC, Thomas JA et al. Lymphokine activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1994; 13: 311-316.
30. Scambia G, Panici PB, Pierelli L et al. Immunological reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation for advanced ovarian cancer. Eur J Cancer 1993; 29A: 1518-1522.
31. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressorinducer subsets. Immunol Today 1988; 9: 195-199.
32. Morimoto C, Letvin N, Boyd AW et al. The isolation and characterization of human helper inducer T cell subsets. J Immunol 1985; 134: 3762-3769.
33. Bell EB, Sparshott SM, Dragson MT, Hunt SV. The origin of T-cells in permanently reconstituted old athymic nude rats. Analysis using chromosome or allotype markers. Immunology 1989; 68: 691-702.
34. Minero R, Busea A, Roncarolo MG et al. HLA-haploidentical umbilical cord blood transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery. Bone Marrow Transplant 1995; 16: 229-240.